
Previous research suggests that insulin may spur the growth of prostate cancer cells.  In type II diabetes, the body fails to properly use insulin, which can lead to an excessive amount of insulin in the blood.  Researchers at Fox Chase Cancer Center found no effects of type II diabetes on aggressiveness of prostate cancer but found that long-term survival is worse. 

